1. Home
  2. LXEO vs JOF Comparison

LXEO vs JOF Comparison

Compare LXEO & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • JOF
  • Stock Information
  • Founded
  • LXEO 2017
  • JOF 1990
  • Country
  • LXEO United States
  • JOF Japan
  • Employees
  • LXEO N/A
  • JOF N/A
  • Industry
  • LXEO
  • JOF Trusts Except Educational Religious and Charitable
  • Sector
  • LXEO
  • JOF Finance
  • Exchange
  • LXEO Nasdaq
  • JOF Nasdaq
  • Market Cap
  • LXEO 140.6M
  • JOF 220.2M
  • IPO Year
  • LXEO 2023
  • JOF N/A
  • Fundamental
  • Price
  • LXEO $2.97
  • JOF $8.26
  • Analyst Decision
  • LXEO Strong Buy
  • JOF
  • Analyst Count
  • LXEO 5
  • JOF 0
  • Target Price
  • LXEO $23.80
  • JOF N/A
  • AVG Volume (30 Days)
  • LXEO 475.1K
  • JOF 43.9K
  • Earning Date
  • LXEO 03-18-2025
  • JOF 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • JOF 3.33%
  • EPS Growth
  • LXEO N/A
  • JOF N/A
  • EPS
  • LXEO N/A
  • JOF N/A
  • Revenue
  • LXEO N/A
  • JOF N/A
  • Revenue This Year
  • LXEO N/A
  • JOF N/A
  • Revenue Next Year
  • LXEO N/A
  • JOF N/A
  • P/E Ratio
  • LXEO N/A
  • JOF N/A
  • Revenue Growth
  • LXEO N/A
  • JOF N/A
  • 52 Week Low
  • LXEO $2.32
  • JOF $6.64
  • 52 Week High
  • LXEO $19.50
  • JOF $8.04
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 37.57
  • JOF 64.29
  • Support Level
  • LXEO $2.51
  • JOF $8.14
  • Resistance Level
  • LXEO $2.95
  • JOF $8.42
  • Average True Range (ATR)
  • LXEO 0.34
  • JOF 0.13
  • MACD
  • LXEO 0.07
  • JOF 0.02
  • Stochastic Oscillator
  • LXEO 40.88
  • JOF 69.81

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About JOF Japan Smaller Capitalization Fund Inc

Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.

Share on Social Networks: